StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report report published on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Down 3.6 %
Shares of CPHI opened at $0.19 on Thursday. The stock has a 50 day moving average price of $0.23 and a 200 day moving average price of $0.24. China Pharma has a one year low of $0.17 and a one year high of $1.16. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.09) EPS for the quarter. The business had revenue of $0.93 million during the quarter. China Pharma had a negative net margin of 85.56% and a negative return on equity of 61.46%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Find and Profitably Trade Stocks at 52-Week Lows
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 10 Best Airline Stocks to Buy
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Using the MarketBeat Stock Split Calculator
- Time to Load Up on Home Builders?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
